Percentage of adults and children enrolled in HIV care and eligible for co-trimoxazole (CTX) prophylaxis (according to national guidelines) currently receiving CTX prophylaxis
Provision and coverage of CTX prophylaxis for adults and children enrolled in HIV care according to national criteria.
Cotrimoxazole (CTX) prophylaxis is a critical intervention for HIV-infected adults and children for prolonging life, reducing greatly the incidence of major opportunistic infections and bacterial infections. It is critical to associate CTX
prophylaxis with ART to prevent infections during immune recovery.
Number of adults and children enrolled in HIV care, eligible for CTX prophylaxis (in accordance with the national CTX prophylaxis guidelines) and receiving it at their last visit (in accordance with the national CTX prophylaxis guidelines) recorded during the reporting period
Number of adults and children enrolled in HIV care and eligible for CTX prophylaxis at their last visit (in accordance with national CTX prophylaxis guidelines) recorded during the reporting period
Despite national policy, CTX prophylaxis is not always fully implemented. In addition low coverage might reflect potential bottlenecks in the system such as poor management of CTX supply, poor data collection and inadequate distribution system.
Additional considerations: This indicator that reflects coverage should also be interpreted in view of the
national recommendations for CTX.
Data utilization: General idea of whether those who require CTX are receiving it. Explore disaggregated value to see whether there are patterns at individual facility of a sub-national level (e.g. stock outs in specific places) which can be addressed.